Default: Expert Opinion on Therapeutic Patents

ISSN: 1354-3776

Journal Home

Journal Guideline

Expert Opinion on Therapeutic Patents Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Opinion on Therapeutic Patents is a journal indexed in SJR in Medicine (miscellaneous) and Drug Discovery with an H index of 93. It has a price of 4000 €. It has an SJR impact factor of 1,2 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,2.

Expert Opinion on Therapeutic Patents focuses its scope in these topics and keywords: patent, inhibitors, activation, agent, agents, anticancer, antitumor, battlesfactor, camptothecin, canada’s, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Expert Opinion on Therapeutic Patents

1,2

SJR Impact factor

93

H Index

71

Total Docs (Last Year)

189

Total Docs (3 years)

7349

Total Refs

992

Total Cites (3 years)

184

Citable Docs (3 years)

4.63

Cites/Doc (2 years)

103.51

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


patent, inhibitors, activation, agent, agents, anticancer, antitumor, battlesfactor, camptothecin, canada’s, central, channels, cyclotides, demethylase, derivatives, developments, diseasesrecent, evaluation, field, general, histone, ht, improvements, injury, ischemichypoxicanoxic, katpand, kppotassium, ligands, literaturerecent, loses, modulatorsrecent, nervous, neuroprotection, peripheral, pharmaceutical, potent, potential, progress,

FAQS